Matt Windsor

Matt Windsor

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Questions employees submitted during the virtual town hall Sept. 11 that could not be addressed due to time constraints are answered here; find responses from leaders on employee recognition, office safety and more.

An interdisciplinary team of faculty and graduate students are using machine learning to identify geographic areas in which social determinants contribute to the COVID-19 burden as a way to improve the public health response.

The immune system’s first responders are implicated in acute respiratory distress syndrome, which greatly increases mortality in patients with COVID-19. With pilot funding from UAB’s urgent COVID-19 research initiative, investigators are exploring a potentially powerful new form of treatment.

The Census deadline is Sept. 30. If you haven’t completed this 10-minute process, here are six ways that 600-second investment will benefit you.

UAB leaders shared insights on the first weeks of fall semester and upcoming parking changes and answered questions on flu shots, residence halls, spring semester and more.

UAB leaders discussed data and reactions from the first weeks of fall semester and answered questions on mask compliance, work restrictions, benefits changes and more.

Depression symptoms are rising during the pandemic, but a new study shows that having a healthy savings account has a protective effect. Free financial counseling from UAB and other employee training resources offer a step-by-step guide to savings success.

Moon Nahm, M.D., has identified the crucial antibodies for pneumococcal vaccines and helped lower prices from $100 per dose to $2. With pilot funding from UAB’s urgent COVID-19 research initiative, Nahm is adapting his proven techniques to SARS-CoV-2.

Alabamians have early access to potentially life-saving vaccines and treatments for COVID-19 through UAB. Why? The same reasons that clinical trials activity at UAB has more than doubled in the past five years. Here's how it happened.

A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.

Page 1 of 20